XWELL, Inc. (XWEL)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 8 | 74 | 56 | 30 | 34 | 29 | 28 | - |
| Operating profit | $m | -9 | -7 | ||||||
| Net profit | $m | -90 | 3 | -33 | -28 | -17 | -17 | -23 | - |
| EPS reported | $ | -5.08 | -5.29 | ||||||
| Operating cashflow per share | $ | -2.61 | -1.23 | ||||||
| Capex per share | $ | 0.89 | 0.40 | ||||||
| FCF per share | $ | -3.49 | -1.63 | ||||||
| Free cash flow | $m | -12 | -13 | ||||||
| Net debt | $m | 1 | -12 | ||||||
| Book value equity | $m | -22 | - | ||||||
| Book value per share | $ | -3.96 | 1.36 | ||||||
| Number of shares | m | 5.56 | 7.94 | ||||||
| DPS (TTM paid) | $ | 0.05 | 0.15 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -0.07 | 18.48 | ||||||
| P/S LTM | x | 0.05 | 0.05 | ||||||
| P/FCF LTM | x | -0.13 | -0.11 | ||||||
| EV/EBITDA LTM | x | -0.81 | -0.53 | ||||||
| EV/Sales LTM | x | 0.39 | -0.03 | ||||||
| Earnings Yield LTM | % | -11.04% | -3.26% | ||||||
| FCF Yield | % | -758.96% | -875.89% | ||||||
| Quality | |||||||||
| ROE | % | +77.10% | +289.35% | ||||||
| ROIC | % | -2.48% | -63.14% | ||||||
| Operating margin | % | -32.03% | -40.28% | ||||||
| Gross margin | % | +22.75% | +26.04% | ||||||
| FCF/Sales | % | -39.98% | -41.86% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -13.83% | -16.56% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +17.35% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | -0.95% | -3.64% | ||||||
| FCF/Debt | x | -0.94 | -1.85 | ||||||
| Net Debt/EBITDA | x | -0.70 | 0.40 | ||||||
| EBIT/Net interest | x | -69.82 | -90.02 | ||||||
| Net debt/market cap | % | +2.33% | 0.00% | ||||||
| Net debt/Equity | x | -0.04 | - | ||||||
| Gross debt/equity | x | -0.57 | - | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free